Prime Capital Investment Advisors, LLC Crispr Therapeutics Ag Transaction History

Prime Capital Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $12,862 - $18,893	212 Added 6.45%	3,499 $238,000
Q4 2023 Jan 24, 2024	BUY	$38.62 - $72.18 $126,943 - $237,255	3,287 New	3,287 $205,000
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $53,142 - $85,316	-527 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$110.72 - $210.04 $28,344 - $53,770	256 Added 94.46%	527 $64,000
Q4 2020 Feb 03, 2021	BUY	$79.67 - $173.23 $3,585 - $7,795	45 Added 19.91%	271 $41,000
Q3 2020 Nov 06, 2020	BUY	$78.5 - $100.64 $17,741 - $22,744	226 New	226 $19,000

484

64.1M

1.64M

1.93M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.93B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.